Pfizer signs deal with Allogene to develop cancer cell therapy

(Reuters) - Pfizer Inc said on Tuesday it signed an agreement with Allogene Therapeutics, a company formed by a consortium in which the drugmaker will hold a 25 percent stake, to further develop its allogenic CAR T cell therapy.

from Reuters: Health News https://ift.tt/2IprWbi